NWBO - Northwest Biotherapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue4123366231,739
Cost of Revenue18,15433,51560,081103,120
Gross Profit-17,742-33,179-59,458-101,381
Operating Expenses
Research Development----
Selling General and Administrative27,01521,49919,80824,903
Non Recurring----
Others----
Total Operating Expenses45,16955,01479,889128,023
Operating Income or Loss-44,757-54,678-79,266-126,284
Income from Continuing Operations
Total Other Income/Expenses Net8,963-18,465-94811,543
Earnings Before Interest and Taxes-44,757-54,678-79,266-126,284
Interest Expense-9,871-5,545-3,818-4,153
Income Before Tax-35,794-73,143-80,214-114,741
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-35,794-73,143-80,214-114,741
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-35,794-73,143-80,214-114,741
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-53,559-74,409-85,861-114,741